{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:22:02Z","timestamp":1787556122044,"version":"build-2736575974"},"reference-count":32,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"2","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>Adenosquamous carcinoma and pure squamous cell carcinoma (SCC) of the rectum are extremely rare malignancies, accounting for approximately 0.15% of all colorectal cancers. Increasing attention has been paid to tumor phenotypic plasticity in the context of intensive anticancer therapy. We report the case of a 45-year-old patient with locally advanced rectal adenocarcinoma (cT4bN2M0) who underwent total neoadjuvant therapy consisting of XELOX chemotherapy combined with pelvic radiotherapy. Baseline biopsy samples from multiple tumor areas showed moderately differentiated adenocarcinoma with an intestinal immunophenotype. After treatment, the resected tumor showed complete loss of intestinal differentiation markers (CK20, CDX2) and the emergence of a squamous immunophenotype with positive expression of p40 and p63. Histologically, the tumor was composed exclusively of poorly differentiated SCC. PCR analysis detected HPV16 DNA in the SCC component. Strong, diffuse p16INK4a expression was observed in both the primary adenocarcinoma and the post-treatment tumor. These findings indicate a marked therapy-associated phenotypic shift in tumor differentiation. However, the underlying biological mechanism remains uncertain. Possible explanations include therapy-associated tumor plasticity, clonal selection of a pre-existing squamous subclone, or an initially unrecognized mixed tumor phenotype. This case highlights the importance of careful pathological reassessment after neoadjuvant therapy in rectal cancer and illustrates the complexity of interpreting phenotypic changes in treated tumors. The potential role of HPV in such processes remains hypothetical and requires further investigation.<\/jats:p>","DOI":"10.15407\/exp-oncology.2026.02.172","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T06:59:57Z","timestamp":1787554797000},"page":"172-180","source":"Crossref","is-referenced-by-count":0,"title":["PHENOTYPIC SHIFT OF ADENOCARCINOMA TO SQUAMOUS CELL CARCINOMA OF RECTUM AFTER NEOADJUVANT CHEMORADIOTHERAPY WITH DETECTION OF HPV16: A CLINICAL CASE"],"prefix":"10.15407","volume":"48","author":[{"given":"O.","family":"Kovalyov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zavhorodniy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Tolok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Anenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kubrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Danilyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kovalyov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"32237","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"18871","doi-asserted-by":"crossref","unstructured":"Astaras C, Bornand A, Koessler T. Squamous rectal carcinoma: A rare malignancy, literature review and management recommendations. ESMO Open. 2021;6(4):100180. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100180","DOI":"10.1016\/j.esmoop.2021.100180"},{"key":"18872","doi-asserted-by":"crossref","unstructured":"Parente P, Mastracci L, Vanoli A, et al. Colorectal adenosquamous carcinoma: Peculiar morphology and different immunoprofiles in squamous and glandular components. Pathol Res Pract. 2022;238:153967. https:\/\/doi.org\/10.1016\/j.prp.2022.153967","DOI":"10.1016\/j.prp.2022.153967"},{"key":"18873","doi-asserted-by":"crossref","unstructured":"Hanahan D. Hallmarks of cancer: New dimensions. Cancer Discov. 2022;12(1):31-46. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"18874","doi-asserted-by":"crossref","unstructured":"Kovalyov OO, Tolok OP, Kovalyov KO. Transformation of adenocarcinoma into small cell lung cancer as a mechanism of acquired resistance to EGFR tyrosine kinase inhibitors. Pathologia. 2024;21(1):84-88. https:\/\/doi.org\/10.14739\/2310-1237.2024.1.298373","DOI":"10.14739\/2310-1237.2024.1.298373"},{"key":"18875","doi-asserted-by":"crossref","unstructured":"Shi ZJ, Pan K, Wu ZX, et al. Plasticity of tumor cells in targeted therapy-induced resistance: Mechanisms and new strategies. Signal Transduct Target Ther. 2023;8(1):113. https:\/\/doi.org\/10.1038\/s41392-023-01383-x","DOI":"10.1038\/s41392-023-01383-x"},{"key":"18876","doi-asserted-by":"crossref","unstructured":"Fioretsaki R, Trifylli EM, Sarantis P, et al. The interplay between esophageal adenocarcinoma and its tumor microenvironment: Toward innovative therapies. Cells. 2025;14(23):1895. https:\/\/doi.org\/10.3390\/cells14231895","DOI":"10.3390\/cells14231895"},{"key":"18877","doi-asserted-by":"crossref","unstructured":"Wang X, Tan C, Wu K, et al. Integrative investigation of adeno-to-squamous transition in lung cancer resistance to EGFR-TKI identifies RAPGEF3 as a therapeutic target. Natl Sci Rev. 2024;11(12):nwae392. https:\/\/doi.org\/10.1093\/nsr\/nwae392","DOI":"10.1093\/nsr\/nwae392"},{"key":"18878","doi-asserted-by":"crossref","unstructured":"Zhong J, Yang L. Histological transformation of rectal adenocarcinoma into choriocarcinoma after surgery and chemotherapy: A rare clinical case and literature review. Int J Surg Case Rep. 2024;117:109478. https:\/\/doi.org\/10.1016\/j.ijscr.2024.109478","DOI":"10.1016\/j.ijscr.2024.109478"},{"key":"18879","doi-asserted-by":"crossref","unstructured":"Johnson GRJ, Park J, Helewa RM, et al. Total neoadjuvant therapy for rectal cancer: A guide for surgeons. Can J Surg. 2023;66(2):E196-E201. https:\/\/doi.org\/10.1503\/cjs.005822","DOI":"10.1503\/cjs.005822"},{"key":"18880","doi-asserted-by":"crossref","unstructured":"Yasui K, Kondo R, Iizuka A, et al. Influence of preoperative chemoradiotherapy on the immunological status of patients with rectal cancer. J Radiat Res. 2020;61(5):766-775. https:\/\/doi.org\/10.1093\/jrr\/rraa041","DOI":"10.1093\/jrr\/rraa041"},{"key":"18881","doi-asserted-by":"crossref","unstructured":"Zhou L, Zhu J, Liu Y, et al. Mechanisms of radiation-induced tissue damage. MedComm (2020). 2024;5(10):e725. https:\/\/doi.org\/10.1002\/mco2.725","DOI":"10.1002\/mco2.725"},{"key":"18882","doi-asserted-by":"crossref","unstructured":"Makadia S, Patel I, Abusaada K. Human papillomavirus-positive squamous cell carcinoma of the rectum. Cureus. 2020;12(7):e9022. https:\/\/doi.org\/10.7759\/cureus.9022","DOI":"10.7759\/cureus.9022"},{"key":"18883","doi-asserted-by":"crossref","unstructured":"Adetiloye AO, Asif A, Badero OJ, et al. Rare diagnosis of HPV-positive rectal squamous cell carcinoma in a 59-year-old heterosexual woman: Implications for screening recommendations. Am J Case Rep. 2025;26:e950554. https:\/\/doi.org\/10.12659\/AJCR.950554","DOI":"10.12659\/AJCR.950554"},{"key":"18884","doi-asserted-by":"crossref","unstructured":"Javadi M, Jalilian S, Kanani M, et al. Time to take HPV infection more seriously in colorectal cancer patients. Front Med (Lausanne). 2024;11:1418359. https:\/\/doi.org\/10.3389\/fmed.2024.1418359","DOI":"10.3389\/fmed.2024.1418359"},{"key":"18885","doi-asserted-by":"crossref","unstructured":"Lieb DA, Thompson HM, Verheij FS, et al. Colonic adenosquamous carcinoma: A single-center review of patient clinicopathologic characteristics, genetics, and clinical outcomes. Cancers (Basel). 2024;16(15):2641. https:\/\/doi.org\/10.3390\/cancers16152641","DOI":"10.3390\/cancers16152641"},{"key":"18886","doi-asserted-by":"crossref","unstructured":"Basavaraj S, Saniha PB, Geethalakshmi U, et al. Primary adenosquamous carcinoma of ascending colon: A rare entity. J Med Sci Health. 2022;8(3):288-291. https:\/\/doi.org\/10.46347\/jmsh.v8i3.22.350","DOI":"10.46347\/jmsh.v8i3.22.350"},{"key":"18887","doi-asserted-by":"crossref","unstructured":"Chohan S, Ahuja S, Sharma A, et al. Collision-type adenosquamous carcinoma of the colon with signet-ring adenocarcinoma: A rare case report. Int J Surg Case Rep. 2025;127:110808. https:\/\/doi.org\/10.1016\/j.ijscr.2024.110808","DOI":"10.1016\/j.ijscr.2024.110808"},{"key":"18888","doi-asserted-by":"crossref","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al. The WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182-188. https:\/\/doi.org\/10.1111\/his.13975","DOI":"10.1111\/his.13975"},{"key":"18889","unstructured":"Nishi T, Weinstein WM, Makuuchi H. Squamous cell metaplasia in the rectum: A case report and review of the medical literature. Tokai J Exp Clin Med. 2004;29(4):163-166. PMID: 15717487"},{"key":"18890","doi-asserted-by":"crossref","unstructured":"Parks A, Jovanov A. HPV, anal and rectal cancer: Gender norms and screening disparities. In: Vannelli A, editor. Rectal and Anal Diseases. London: IntechOpen; 2025. https:\/\/doi.org\/10.5772\/intechopen.1008798","DOI":"10.5772\/intechopen.1008798"},{"key":"18891","doi-asserted-by":"crossref","unstructured":"Pan PH, Luo CW, Ting WC, et al. Impact of ascending HPV infection on the risk of colorectal cancer. Microorganisms. 2024;12:1746. https:\/\/doi.org\/10.3390\/microorganisms12091746","DOI":"10.3390\/microorganisms12091746"},{"key":"18892","doi-asserted-by":"crossref","unstructured":"Mitoyan L, Chevrier V, Hernandez-Vargas H, et al. A stem cell population at the anorectal junction maintains homeostasis and participates in tissue regeneration. Nat Commun. 2021;12:2761. https:\/\/doi.org\/10.1038\/s41467-021-23034-x","DOI":"10.1038\/s41467-021-23034-x"},{"key":"18893","doi-asserted-by":"crossref","unstructured":"Gupta PB, Pastushenko I, Skibinski A, et al. Phenotypic plasticity: Driver of cancer initiation, progression, and therapy resistance. Cell Stem Cell. 2019;24(1):65-78. https:\/\/doi.org\/10.1016\/j.stem.2018.11.011","DOI":"10.1016\/j.stem.2018.11.011"},{"key":"18894","doi-asserted-by":"crossref","unstructured":"Liu YP, Zheng CC, Huang YN, et al. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm (2020). 2021;2(3):315-340. https:\/\/doi.org\/10.1002\/mco2.55","DOI":"10.1002\/mco2.55"},{"key":"18895","doi-asserted-by":"crossref","unstructured":"Micu A, Diaconescu A, Mincuna CE, et al. Overcoming the challenge: Resistance to neoadjuvant treatment in rectal cancer. J Gastrointest Cancer. 2025;56:205. https:\/\/doi.org\/10.1007\/s12029-025-01324-7","DOI":"10.1007\/s12029-025-01324-7"},{"key":"18896","doi-asserted-by":"crossref","unstructured":"Zhang N, Tong H, Ji H. Squamous transition drives drug resistance. Clin Transl Med. 2024;14(6):e1697. https:\/\/doi.org\/10.1002\/ctm2.1697","DOI":"10.1002\/ctm2.1697"},{"key":"18897","doi-asserted-by":"crossref","unstructured":"Audeau A, Han HW, Johnston MJ, et al. Does human papillomavirus have a role in squamous cell carcinoma of the colon and upper rectum? Eur J Surg Oncol. 2002;28(6):657-660. https:\/\/doi.org\/10.1053\/ejso.2002.1304","DOI":"10.1053\/ejso.2002.1304"},{"key":"18898","doi-asserted-by":"crossref","unstructured":"Hsu CH, Lin YJ, Chen YC, et al. Human papillomavirus and risk of colorectal cancer: An analysis of nationwide claims data. Medicina (Kaunas). 2022;58(10):1461. https:\/\/doi.org\/10.3390\/medicina58101461","DOI":"10.3390\/medicina58101461"},{"key":"18899","doi-asserted-by":"crossref","unstructured":"Santos NC, Tocantins P, Le\u00e3o-Cordeiro JAB, et al. The human papillomavirus in colorectal cancer. J Med Sci. 2021;42(1):1-7. https:\/\/doi.org\/10.4103\/jmedsci.jmedsci_194_20","DOI":"10.4103\/jmedsci.jmedsci_194_20"},{"key":"18900","doi-asserted-by":"crossref","unstructured":"Dalla Libera LS, de Siqueira T, Santos IL, et al. Detection of human papillomavirus and the role of p16INK4a in colorectal carcinomas. PLoS One. 2020;15(6):e0235065. https:\/\/doi.org\/10.1371\/journal.pone.0235065","DOI":"10.1371\/journal.pone.0235065"},{"key":"18901","unstructured":"Hafez F, Refaat G, Alorabi M, et al. Interpretation of p16 expression as a marker of HPV in colorectal carcinoma. Histol Histopathol. 2022;37(5):455-463. https:\/\/doi.org\/10.14670\/HH-18-439"},{"key":"18902","unstructured":"Submitted: February 02, 2026"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/652\/478","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/652\/478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:00:01Z","timestamp":1787554801000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2026.02.172","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"value":"2312-8852","type":"electronic"},{"value":"1812-9269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}